Method for preparing calcobutrol
Inventors
Lim, Geun Jho • Chang, Sun Ki • Byeon, Chang Ho • YOON, Hoe Jin • Kim, Moon Soo
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
Disclosed is a novel method of preparing highly pure calcobutrol using an intermediate (butrol) of gadobutrol without using highly pure gadobutrol. This method is capable of obtaining calcobutrol at high purity and high yield through a simple and environmentally friendly process, and thus can be easily applied to mass production.
Core Innovation
The disclosed subject matter addresses problems associated with existing calcobutrol preparations, including insufficient purity and economic disadvantage associated with handling of highly pure gadobutrol. Calcobutrol is described as the calcium complex of the butrol ligand, and the disclosure introduces a synthetic route that avoids relying on highly pure gadobutrol while targeting highly pure calcobutrol.
The method prepares a compound of Formula 1 (calcobutrol) through a three-step sequence involving intermediates of Formula 2, Formula 3, and Formula 4. In (S1), a compound of Formula 3 is prepared from a compound of Formula 2 or a salt thereof using a Formula 5 reagent, and in (S2), the compound of Formula 3 is converted to a compound of Formula 4 by acid hydrolysis, with optional resin purification and crystallization.
In (S3), the compound of Formula 1 (calcobutrol) is prepared from the compound of Formula 4 using a calcium ion source and optional crystallization. The disclosure further states suitability for mass production and provides examples with high-purity intermediates and calcobutrol.
Claims Coverage
The independent claim covers a three-step method that constructs calcobutrol (Formula 1) from a Formula 2 starting compound via a Formula 3 intermediate and a Formula 4 conversion step, with R restricted to linear or branched C1-C4 alkyl. The provided refinements specify the (S1) reagent and solvent/base system, salt form, (S2) acid hydrolysis and crystallization solvents, and (S3) calcium ion source selection.
Three-step preparation of calcobutrol from Formula 2 via Formula 3 and Formula 4
A method for preparing a compound of Formula 1 (calcobutrol) comprising: (S1) preparing a compound of Formula 3 from a compound of Formula 2 or a salt thereof; (S2) preparing a compound of Formula 4 from the compound of Formula 3; and (S3) preparing a compound of Formula 1 from the compound of Formula 4, wherein R is a linear or branched-chain C1-C4 alkyl group.
Using a Formula 5 reagent with a specified solvent/base system in (S1)
The (S1) step reacts the compound of Formula 2 with a compound of Formula 5 in a solvent mixture of water, a C4-C11 ether, and an inorganic base, with X being halogen, tosylate, or mesylate.
Hydrochloride salt form for the Formula 2 starting material in (S1)
The (S1) step includes that the salt of the compound of Formula 2 is the hydrochloride of Formula 6 (4HCl).
Acid hydrolysis conversion in (S2)
The (S2) step includes acid hydrolysis.
Crystallization solvent selection in (S2)
During crystallization in the (S2) step, the solvent is methanol, acetone, or a mixture thereof.
Calcium ion source selection in (S3)
In (S3), the calcium ion source is calcium carbonate, calcium chloride, calcium oxalate, calcium phosphate, or calcium hydroxide.
Across the independent claim and its provided refinements, the core claim coverage is the three-step preparation of calcobutrol (Formula 1) from Formula 2 through Formula 3 and Formula 4 with R as linear or branched C1-C4 alkyl, further constrained by the specified (S1) reagent/solvent/base and X, salt form (4HCl), (S2) acid hydrolysis with specified crystallization solvents, and (S3) calcium ion source selection.
Stated Advantages
Avoids using highly pure gadobutrol.
Provides highly pure calcobutrol.
Economically advantageous compared to prior approaches involving gadobutrol handling.
Mild processing and suitable for mass production.
Documented Applications
No documented applications found
Interested in licensing this patent?